Today: 16 April 2026
Goldman Sachs stock slips after top lawyer’s Epstein-linked exit as CPI cools
13 February 2026
2 mins read

Goldman Sachs stock slips after top lawyer’s Epstein-linked exit as CPI cools

New York, Feb 13, 2026, 10:49 EST — Regular session.

Goldman Sachs Group Inc shares dropped roughly 0.7% to $898.00 on Friday following news that chief legal officer Kathy Ruemmler is resigning as questions mount over her previous connections to Jeffrey Epstein. Shares touched a low of $869.80 before trimming some of the decline, with trading volume hitting about 1.1 million shares.

The resignation hits financial stocks during an uneasy session, as traders revisit their interest-rate bets following a milder inflation print. The Consumer Price Index was up 0.2% in January, a notch below the 0.3% economists had penciled in. Core CPI, which leaves out food and energy, advanced 0.3%.

Big banks were already reeling from Thursday’s sharp drop, even before Goldman’s own headline landed. The S&P 500 slumped 1.57%, while the Nasdaq lost nearly 2% as traders dialed back exposure to riskier stocks, spooked by fresh chatter about AI shaking up the landscape. “We see this as a ‘prove it’ year for AI,” said Jack Herr, primary investment analyst at GuideStone Funds. Reuters

Ruemmler announced in a statement that she’s stepping down as chief legal officer and general counsel effective June 30. According to AP, Goldman has a policy requiring staff to get preapproval for gifts, aiming to sidestep conflicts of interest and anti-bribery concerns.

David Solomon, the chief executive, described her resignation as something he “reluctantly accepted,” telling CNBC the media scrutiny was turning into too big a distraction for the company. “I respect her decision,” Solomon added. Reuters

The Justice Department’s disclosures have traced years of email correspondence and gift giving between Ruemmler and Epstein—she called him “Uncle Jeffrey” in some messages, according to the Irish Times. Ruemmler has since said she wishes she’d never met Epstein, expressing “sympathy and heartache” for his victims. The Irish Times

Goldman shares wrapped up Thursday at $904.55, a notable drop from Wednesday’s $944.59 close. The stock bounced between a session high of $968.39 and a low of $903.98, Yahoo Finance historical data shows.

Large financial stocks took a hit in a rough session: Morgan Stanley dropped 4.88%, Goldman sank 4.24%, and Bank of America shed 2.47%, according to MarketWatch data.

Goldman’s action carries added weight for index trackers: the Dow is price-weighted, so pricier stocks have more sway. Each $1 change in any Dow name nudges the index about 6 points. A big move in Goldman shows up fast in the Dow’s headline numbers.

Inflation isn’t a one-way street for banks. A Reuters Breakingviews piece pointed out that softer headline CPI figures leave the door open for rate cuts, though analysts noted some stubborn spots in the data. “Core services (excluding shelter) remains strong,” Josh Jamner observed. Phil Orlando, on the other hand, took the report as a sign that rate easing remains on the table. Reuters

Investors are waiting for clarity on Goldman’s plans to fill the general counsel spot after Ruemmler steps down June 30, and watching to see if more Epstein documents come out. The macro calendar is anchored by the Federal Reserve’s policy meeting March 17-18—rate decision and press conference both set for March 18.

Stock Market Today

  • AstraZeneca and GSK Lead UK Fund Managers' Top 10 Holdings
    April 16, 2026, 4:53 AM EDT. More than half of funds in the IA UK All Companies sector list pharmaceutical giants AstraZeneca and GSK in their top 10 holdings. AstraZeneca is held by 57.4% of funds, reflecting its 9% weight in the FTSE 100 and strong five-year share performance. GSK appears in 50.7% of funds' top 10, favored particularly among income-focused portfolios. The UK market's shrinking pool of stocks, due to mergers and a lack of IPOs, may be driving managers towards these large, stable healthcare companies as core holdings. Active and passive funds alike show significant allocations, with some holding over 9% in AstraZeneca and over 6% in GSK.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 16.04.2026

16 April 2026
LIVEMarkets rolling coverageStarted: April 16, 2026, 12:00 AM EDTUpdated: April 16, 2026, 5:03 AM EDT AstraZeneca and GSK Lead UK Fund Managers' Top 10 Holdings April 16, 2026, 4:53 AM EDT. More than half of funds in the IA UK All Companies sector list pharmaceutical giants AstraZeneca and GSK in their top 10 holdings. AstraZeneca is held by 57.4% of funds, reflecting its 9% weight in the FTSE 100 and strong five-year share performance. GSK appears in 50.7% of funds' top 10, favored particularly among income-focused portfolios. The UK market's shrinking pool of stocks, due to mergers and a lack
Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Performance Food Group stock steadies near $98 after an 8% surge — here’s what Wall Street is watching
Previous Story

Performance Food Group stock steadies near $98 after an 8% surge — here’s what Wall Street is watching

Linde stock jumps nearly 3% as Wall Street steadies; what traders watch next
Next Story

Linde stock jumps nearly 3% as Wall Street steadies; what traders watch next

Go toTop